SEC Filing - Mobia Medical

SCHEDULE 13G

CUSIP No.

Names of Reporting Persons

Synapse Investment, LP

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

Sec Use Only

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,986,072.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,986,072.00

Aggregate Amount Beneficially Owned by Each Reporting Person

1,986,072.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in row (9)

6.0 %

Type of Reporting Person (See Instructions)

SCHEDULE 13G

CUSIP No.

Names of Reporting Persons

Synapse Investment Partners I, LP

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

Sec Use Only

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,986,072.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,986,072.00

Aggregate Amount Beneficially Owned by Each Reporting Person

1,986,072.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in row (9)

6.0 %

Type of Reporting Person (See Instructions)

SCHEDULE 13G

CUSIP No.

Names of Reporting Persons

Synapse Investment Partners, LLC

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

Sec Use Only

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,986,072.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,986,072.00

Aggregate Amount Beneficially Owned by Each Reporting Person

1,986,072.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in row (9)

6.0 %

Type of Reporting Person (See Instructions)

SCHEDULE 13G

CUSIP No.

Names of Reporting Persons

Simeon George

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

Sec Use Only

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,986,072.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,986,072.00

Aggregate Amount Beneficially Owned by Each Reporting Person

1,986,072.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in row (9)

6.0 %

Type of Reporting Person (See Instructions)

SCHEDULE 13G

Item 1.

(a)

Name of issuer:

Mobia Medical, Inc.

(b)

Address of issuer's principal executive offices:

2802 Flintrock Trace, Suite 226, Austin, TX 78738

Item 2.

(a)

Name of person filing:

Synapse Investment, LP ("Synapse"); Synapse Investment Partners I, LP ("Partners I"); Synapse Investment Partners, LLC ("Partners"); and Simeon George, M.D. ("Dr. George"). Partners I is the general partner of Synapse. Partners is the sole general partner of Partners I. Dr. George is the managing member of Partners. Partners I, Partners, and Dr. George share voting and dispositive power with respect to the securities directly held by Synapse. The persons named in this Item 2(a) are referred to individually herein as a "Reporting Person" and collectively as the "Reporting Persons."

(b)

Address or principal business office or, if none, residence:

The address of the principal business office of each Reporting Person is c/o SR One Capital Management, LP, 929 Main Street, Suite 200, Redwood City, CA 94063.

(c)

Citizenship:

Synapse and Partners I are each limited partnerships organized under the laws of the State of Delaware. Partners is a limited liability company organized under the laws of the State of Delaware. Dr. George is a United States citizen.

(d)

Title of class of securities:

Common Stock, $0.01 par value per share

(e)

CUSIP No.:

Item 3.

If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

(b)

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

(c)

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

(d)

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

(e)

An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f)

An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g)

A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h)

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)

A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:

(k)

Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

Item 4.

Ownership

(a)

Amount beneficially owned:

The information in Items 1 and 5 through 11 on the cover page for each Reporting Person of this Schedule 13G is hereby incorporated by reference.

(b)

Percent of class:

See Line 11 of cover sheets. %

(c)

Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote:

See Line 5 of cover sheets.

(ii) Shared power to vote or to direct the vote:

See Line 6 of cover sheets.

(iii) Sole power to dispose or to direct the disposition of:

See Line 7 of cover sheets.

(iv) Shared power to dispose or to direct the disposition of:

See Line 8 of cover sheets.

Item 5.

Ownership of 5 Percent or Less of a Class.

Item 6.

Ownership of more than 5 Percent on Behalf of Another Person.

Not Applicable

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not Applicable

Item 8.

Identification and Classification of Members of the Group.

Not Applicable

Item 9.

Notice of Dissolution of Group.

Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Synapse Investment, LP

Signature:	/s/ Sasha Keough
Name/Title:	Sasha Keough, General Counsel and Chief Compliance Officer
Date:	05/18/2026

Synapse Investment Partners I, LP

Signature:	/s/ Sasha Keough
Name/Title:	Sasha Keough, General Counsel and Chief Compliance Officer
Date:	05/18/2026

Synapse Investment Partners, LLC

Signature:	/s/ Sasha Keough
Name/Title:	Sasha Keough, General Counsel and Chief Compliance Officer
Date:	05/18/2026

Simeon George

Signature:	/s/ Sasha Keough
Name/Title:	Sasha Keough, as attorney-in-fact for Simeon George
Date:	05/18/2026

Comments accompanying signature: This Schedule 13G was executed by Sasha Keough on behalf of the individual listed above pursuant to a Power of Attorney, a copy of which is attached as Exhibit 2.

Exhibit Information

Exhibit 1 - Agreement regarding filing of joint Schedule 13G. Exhibit 2 - Power of Attorney regarding filings under the Securities Exchange Act of 1934, as amended.

Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of stock of Mobia Medical, Inc.

*/s/ Sasha Keough                          

This Agreement relating to Schedule 13G was executed by Sasha Keough on behalf of the individual listed above pursuant to a Power of Attorney, a copy of which is attached hereto as Exhibit 2.

Know all by these presents, that the undersigned hereby makes, constitutes and appoints Sasha Keough, Karen Narolewski-Engel, James Macadam, and Alexander M. Bowling, and each of them singly, as each of the undersigned’s true and lawful attorneys-in-fact with full power and authority as hereinafter described to:

1. execute for and on behalf of each of the undersigned individual and entities (each, a “Filer” and collectively, the “Filers”) (i) Forms 3, 4, and 5 (including amendments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules thereunder, (ii) Form 144 in accordance with Rule 144 under the Securities Act of 1933, as amended (the “Securities Act”), and (iii) Schedules 13D and 13G (including amendments thereto) in accordance with Sections 13(d) and 13(g) of the Exchange Act and the rules thereunder;

2. do and perform any and all acts for and on behalf of each of the Filers which may be necessary or desirable to complete and execute any such Form 3, 4, or 5 (including amendments thereto), Form 144, or Schedule 13D or 13G (including amendments thereto) and timely file such form with the United States Securities and Exchange Commission (the “SEC”) and any stock exchange or similar authority, including, but not limited to, executing a Form ID or Update Passphrase request for and on behalf of each of the undersigned and filing such applications with the SEC; and

3. take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, a Filer, it being understood that the documents executed by such attorney-in-fact on behalf of such Filer pursuant to this Limited Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

Each of the Filers hereby grants to each attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes a Filer might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all the acts such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this Limited Power of Attorney and the rights and powers herein granted. Each of the Filers acknowledges that each of the foregoing attorneys-in-fact, in serving in such capacity at the request of such Filer, is not assuming any of such Filer’s responsibilities to comply with Sections 13 or 16 of the Exchange Act or Rule 144 under the Securities Act.

This Limited Power of Attorney shall remain in full force and effect until a Filer is no longer required to file Forms 3, 4, and 5 (including amendments thereto), Form 144, and Schedules 13D and 13G (including amendments thereto) with respect to such Filer’s holdings of and transactions in securities, unless earlier revoked by such Filer in a signed writing delivered to each of the foregoing attorneys-in-fact. In addition, at such time as any attorney-in-fact resigns as attorney-in-fact by the execution of a written resignation delivered to each Filer, without any action on the part of the Filers, this Limited Power of Attorney shall be partially revoked solely with respect to such individual; such individual shall cease to be an attorney-in-fact under this Limited Power of Attorney; and the authority of the other attorneys-in-fact then existing hereunder shall remain in full force and effect.

IN WITNESS WHEREOF, each of the undersigned has caused this Limited Power of Attorney to be executed as of this 12th day of December, 2022.

/s/ Simeon George                                                  

By:      /s/ Simeon George                                      